Core Viewpoint - The company has announced its profit distribution and capital reserve fund conversion plan, which includes cash dividends and stock increases for shareholders based on the adjusted total share capital as of December 31, 2024 [2][3][8]. Profit Distribution and Capital Reserve Conversion Plan - The company will distribute cash dividends of RMB 7.3 per 10 shares (including tax) to all shareholders, totaling RMB 98,374,362 [2][3][8]. - The company will also increase its capital reserve by converting 4 shares for every 10 shares held, resulting in an increase of 53,903,760 shares, bringing the total share capital to 189,141,160 shares [2][3][8]. - The base for the distribution is calculated from the total share capital of 135,237,400 shares, excluding 478,000 shares held in the repurchase account [2][3][8]. Shareholder Meeting and Approval - The profit distribution and capital reserve conversion plan was approved at the annual shareholder meeting held on May 15, 2025 [3][6][11]. - The plan is consistent with the distribution scheme approved at the shareholder meeting and will be implemented within two months of the approval [6][7]. Adjustments and Calculations - The cash dividend per share, after adjustments, is calculated to be approximately RMB 0.7274197, and the stock increase per share is approximately 0.3985861 shares [3][11]. - The ex-dividend and ex-rights price will be adjusted according to the new share capital and distribution ratios [3][11]. Important Dates - The record date for shareholders is June 6, 2025, and the ex-dividend date is June 9, 2025 [12]. - The new shares from the capital increase will be credited to shareholders' accounts on June 9, 2025 [10][12]. Consultation and Documentation - The company has provided contact information for inquiries regarding the distribution plan and has listed documents related to the shareholder meeting and board resolutions for reference [13].

Core Viewpoint - 华盛昌 is actively engaged in the development of safety protection products for the petrochemical industry, with a focus on gas detection and environmental monitoring technologies [1][2]. Group 1: Product Offerings - 华盛昌 offers a diverse range of products for safety protection in the petrochemical sector, including: - GD-3806, a high-precision four-in-one combustible gas detector capable of detecting ammonia, hydrogen sulfide, carbon monoxide, oxygen, and explosive gas concentrations [1]. - CH-9980, a high-precision methane remote sensing device utilizing laser detection technology for non-contact methane leak monitoring [1]. - DT-1990H, a handheld multifunctional detection device that employs microphone array beamforming technology for real-time sound field data collection [1]. Group 2: Financial Information - As of May 28, 2025, 华盛昌's stock closed at 26.88 yuan, with a trading volume of 13,100 shares and a turnover of 35.27 million yuan [1]. - The company announced a cash dividend of 7.3 yuan per 10 shares (including tax) and a capital reserve increase of 4 shares for every 10 shares held, based on a total share capital of 134,759,400 shares [2][4]. - The total cash dividend distribution amounts to 98,374,362 yuan (including tax), and the capital increase will result in a total share capital of 189,141,160 shares post-distribution [2][4].

华盛昌（002980）日前官宣发布新产品HX-660双水平无创呼吸机，该款呼吸机系一款居家智慧医疗设 备，主打睡眠呼吸暂停、低通气综合症人群，搭载智能双压调节技术，可控制和调节人的生理呼吸，改 善呼吸功能，尤其适合复杂呼吸问题。 信达证券（601059）报告显示，2025年全球家用无创呼吸机市场规模预计达55.77亿美元(约合人民币 400亿元)，2020—2025年复合增长率(CAGR)为15.5%。2025年中国家用无创呼吸机市场规模预计达33.3 亿元，2021—2025年CAGR为22.0%，增速高于全球市场。据统计，国内约1.76亿人因阻塞性睡眠呼吸 暂停影响睡眠，而家用呼吸机是解决该类睡眠问题的首选辅助治疗设备。目前，这一设备的渗透率还不 足1%，未来提升空间巨大。 据华盛昌介绍，本次发布的HX-660智能双水平呼吸机内置多个传感器，通过双压动态调节，可自适应 呼吸节奏，同时可以准确实时识别漏气情况，并自动上升压力补偿泄露的气体压力，提高使用舒适性。 此外，HX-660内置数据传输模块，可实现实时显示压力情况并记录、分析数据，可视化呈现睡眠质 量。 相比传统单水平无创呼吸机只能提供恒定压力，主要适 ...

在保证本次权益分派方案不变的前提下，2024年年度权益分派实施后的除权 除息价格按照上述原则及计算方式执行，即本次权益分派实施后的除权除息价格 =（股权登记日收盘价-0.7274197）÷（1+0.3985861）。 一、股东大会审议通过利润分配和资本公积金转增股本方案的相关情况 年度利润分配和资本公积金转增股本方案：以公司 2024 年 12 月 31 日总股本 按总股本（含回购专用账户持有股份）折算后的每股转增股数=（本次实际 参与分配的股本数×实际分派的每股转增股数）÷本次权益分派股权登记日总股 本=（134,759,400×0.4）÷135,237,400，即每股转增股数为0.3985861股，每10股 转增股数为3.985861股。 证券代码：002980 证券简称：华盛昌 公告编号：2025-024 深圳市华盛昌科技实业股份有限公司 本公司及公司全体董事会成员保证信息披露的内容真实、准确、完整，没 有虚假记载、误导性陈述或重大遗漏。 特别提示： 本次利润分配和资本公积金转增股本方案 ：以公司2024年12月31日总股本 （135,237,400股）扣除回购专用账户已回购股份（478,000股）后股 ...

证券代码：002980 证券简称：华盛昌 公告编号：2025-024 深圳市华盛昌科技实业股份有限公司 2024 年年度分红、转增股本实施公告 本公司及公司全体董事会成员保证信息披露的内容真实、准确、完整，没 有虚假记载、误导性陈述或重大遗漏。 特别提示： 1、深圳市华盛昌科技实业股份有限公司（以下简称"公司"、"本公司"） 本次利润分配和资本公积金转增股本方案：以公司2024年12月31日总股本 （135,237,400股）扣除回购专用账户已回购股份（478,000股）后股本134,759,400 股为基数，向全体股东每10股派发现金股利人民币7.3元（含税），以资本公积金 向全体股东每10股转增4股，不送红股。合计派发现金股利98,374,362元（含税）， 以资本公积金转增股本53,903,760股，转增后公司总股本变更为189,141,160股（最 终以中国证券登记结算有限责任公司深圳分公司登记为准）。 2、公司本次分配方案未以总股本为基数实施存在差异化安排：因公司回购 专户中的股份不参与利润分配，本次权益分派实施后，根据股票市值不变原则， 除权除息价格计算时，按股权登记日的总股本（含回购专用账户持有 ...

Core Viewpoint - During the "6.18" promotion, outward-oriented industrial enterprises are leveraging e-commerce platforms to expand into the domestic market, seeking new growth points and promoting product innovation through diverse domestic application scenarios, thereby enhancing the global competitiveness of Chinese manufacturing [2][3]. Group 1: Company Initiatives - Shenzhen Huashengchang Technology Industrial Co., Ltd. plans to launch an AI power quality analyzer in collaboration with JD.com during the "6.18" event, aimed at promoting domestic product substitution [2]. - Huashengchang's revenue for the previous year was 807 million yuan, with a year-on-year growth of 20.55%, and 717 million yuan of that revenue came from overseas, accounting for 88.75% of total revenue [3]. - The company is actively developing AI technology and has created vertical AI models to enhance its product offerings, aiming to gain greater competitiveness in the global market [4]. Group 2: Market Challenges - Companies transitioning from export to domestic sales face challenges such as a lack of talent familiar with domestic marketing and consumer insights, the need to adapt management systems towards digitalization, and the necessity to understand domestic consumption trends [5]. - Huashengchang has encountered difficulties in the domestic market, including issues with intellectual property respect and competition from low-cost, low-quality imitations [5]. Group 3: Industry Trends - The MRO (Maintenance, Repair, and Operations) platform market in China is gradually rising, with platforms like JD Industrial, Xiyu, and Zhenkunxing emerging to support industrial enterprises [6][7]. - The industry is moving towards an "integrated internal and external trade" model, utilizing digital tools for demand forecasting and inventory optimization, and aiming to create a flexible production line to reduce costs [7].

登录新浪财经APP 搜索【信披】查看更多考评等级 本公司及公司全体董事会成员保证信息披露的内容真实、准确、完整，没有虚假记载、误导性陈述或重 大遗漏。 特别提示： 1、本次股东大会无增加、变更、否决议案的情况； 2、本次股东大会不涉及变更以往股东大会已通过的决议； 3、本次股东大会采取现场投票与网络投票相结合的表决方式。 一、会议召开和出席情况 1、会议召集人：公司董事会。 2、会议召开时间： （1）现场会议时间：2025年5月15日（星期四）下午15:00； （2）通过深圳证券交易所交易系统进行网络投票的时间为：2025年5月15日上午9:15-9:25、9:30- 11:30、下午13:00-15:00；通过深圳证券交易所互联网投票系统（http://wltp.cninfo.com.cn）进行网络投 票的时间为：2025年5月15日9:15-15:00的任意时间。 3、会议召开方式：采用现场表决与网络投票相结合的方式召开。 4、会议主持人：董事长袁剑敏。 5、会议召开的合法、合规性：本次股东大会会议召开符合有关法律、行政法规、部门规章、规范性文 件和《公司章程》的规定。 6、现场会议地点：深圳市南山区西丽 ...

证券代码：002980 证券简称：华盛昌 公告编号：2025-023 深圳市华盛昌科技实业股份有限公司 2024 年年度股东大会决议公告 本公司及公司全体董事会成员保证信息披露的内容真实、准确、完整，没 有虚假记载、误导性陈述或重大遗漏。 特别提示： 1、本次股东大会无增加、变更、否决议案的情况； 2、本次股东大会不涉及变更以往股东大会已通过的决议； 3、本次股东大会采取现场投票与网络投票相结合的表决方式。 一、会议召开和出席情况 1、会议召集人：公司董事会。 2、会议召开时间： （1）现场会议时间：2025 年 5 月 15 日（星期四）下午 15:00； （2）通过深圳证券交易所交易系统进行网络投票的时间为：2025 年 5 月 15 日上午 9:15-9:25、9:30-11:30、下午 13:00-15:00；通过深圳证券交易所互联网投 票系统（http://wltp.cninfo.com.cn）进行网络投票的时间为：2025 年 5 月 15 日 9:15-15:00 的任意时间。 3、会议召开方式：采用现场表决与网络投票相结合的方式召开。 4、会议主持人：董事长袁剑敏。 5、会议召开的合法、合规性 ...

1 法律意见书 广东华商律师事务所 关于深圳市华盛昌科技实业股份有限公司 2024年年度股东大会的 法律意见书 二○二五年五月十五日 法律意见书 致：深圳市华盛昌科技实业股份有限公司 广东华商律师事务所（以下简称"本所"）接受深圳市华盛昌科技实业股份 有限公司（以下简称"公司"）的委托，指派本所周玉梅律师、李世琦律师（以 下简称"本所律师"）出席公司2024年年度股东大会（以下简称"本次会议"）。 本所律师依据《中华人民共和国证券法》（以下简称"《证券法》"）、《中华 人民共和国公司法》（以下简称"《公司法》"）、《上市公司股东会规则》等 法律、法规和规范性法律文件以及《深圳市华盛昌科技实业股份有限公司章程》 （以下简称"《公司章程》"）的规定，出具本法律意见书。 本法律意见书仅对本次会议召集和召开的程序、出席本次会议人员的资格、 召集人资格及表决程序是否符合相关法律、法规和《公司章程》的规定以及本次 会议审议议案的表决结果是否有效进行核查并发表意见，并不对本次会议所审议 的议案内容以及该等议案所涉及的事实或数据的真实性和准确性发表意见。 本所律师同意将本法律意见书作为公司本次会议的必备文件予以公告，并依 法 ...

Financial Performance - In Q1 2025, the company achieved revenue of 40,369.1 million RMB, a year-on-year increase of 26.47% [2] - The net profit attributable to shareholders was 29,159.5 million RMB, reflecting a growth of 6.25% compared to the previous year [2] - Excluding the impact of share-based payments, the net profit attributable to shareholders was 37,633.9 million RMB, with a growth rate of 37.13% [2][3] Future Performance Goals - The company has set performance targets for 2024 to 2026, aiming for net profit or revenue growth rates of 25%, 50%, and 75% respectively compared to 2023 [3] - The management maintains a positive outlook for the 2025 performance assessment [3] Dividend Policy - The company is committed to a sustainable and stable profit distribution policy, adhering to legal requirements and considering shareholder interests [3] - The proposed dividend for 2024 is 7.3 RMB per 10 shares (tax included), with a capital reserve conversion of 4 additional shares for every 10 shares held [4] Growth Drivers - The company’s revenue for 2024 was 80,749.78 million RMB, a year-on-year increase of 20.55%, with a net profit of 13,842.49 million RMB, reflecting a growth of 29.21% [5] - Key growth factors include product structure optimization, increased revenue from proprietary brands, and a focus on large customer development strategies [6] Market Strategy - The company has diversified its global marketing strategy to mitigate risks associated with the U.S. market, maintaining stable operations and production capacity in Vietnam [8] - The medical diagnostics and life sciences analysis instruments segment is a strategic focus, with plans to integrate AI technology into existing products [9][11] R&D Investment - R&D investment has increased from 47.17 million RMB in 2020 to 90.45 million RMB in 2024, with a compound annual growth rate of 19.4% [13] - The focus areas for R&D include integrating large model technology into smart instruments and expanding the product matrix to align with international standards [13]